Skin
Malignant melanoma
A malignant tumour of melanocytes, linked to sun exposure in fair skin; it spreads first along the epidermis, then grows down into the dermis, and its depth decides the prognosis.
الأسباب وعوامل الخطر
- Ultraviolet light in light-skinned people
- Dysplastic nevus syndrome (familial melanoma), CDKN2A (p16) mutations
- BRAF, NRAS and TERT mutations
علم الأمراض العياني
- A pigmented lesion with Asymmetry, irregular Borders, varied Colour, a growing Diameter and Evolution in appearance.
تحت المجهر
- Large polygonal or spindle cells with pleomorphic nuclei and prominent nucleoli, making variable amounts of melanin (some are amelanotic).
- Nests invading the dermis in the vertical growth phase, with lymphocytes around them.
كيف يتطور
- Radial growth phase: atypical melanocytes spread along the epidermis.
- Vertical growth phase: nests invade down into the dermis, often forming a nodule.
- Once deep, it can metastasise to lymph nodes and distant sites.
المضاعفات
- Lymph node and distant metastases
- Prognosis set by the depth of invasion (under 1 mm is better)
الاستقصاءات
- Dermoscopy
- An irregular, atypical pigment network.
- Excision biopsy
- Confirms melanoma; Breslow thickness, ulceration and mitotic rate determine the stage and prognosis.
- Sentinel lymph node biopsy
- Spread to the draining lymph nodes.
- CT or PET-CT, and BRAF testing
- Metastases in advanced disease; BRAF mutations guide targeted treatment.
العلاج الدوائي
- Immune checkpoint inhibitors: Antibodies that release the brakes on T cells (PD-1, PD-L1, CTLA-4) so the immune system attacks the tumour; they transformed melanoma, renal cell, lung and liver cancer and Hodgkin lymphoma, but can trigger autoimmune damage to any organ.
- BRAF and MEK inhibitors: Targeted drugs for tumours with a BRAF V600 mutation, about half of melanomas: a BRAF inhibitor combined with a MEK inhibitor blocks the MAPK pathway at two points.
التشريح المعني
موضوعات مرتبطة
مكتوب من
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 16, The Skin, pp. 415–416, figs 16-17 to 16-21
مرجع تعليمي، وليس استشارة طبية أو تشخيصاً أو علاجاً.